Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Delek US Holdings Reports Quarterly Loss and Strategic Initiatives for Future Growth

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Renewable-energy
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Delek US Holdings (NYSE: DK) disclosed a quarterly loss of $(1.46) per share on February 27, 2024, which was below the analyst consensus estimate of $(1.27) by 14.96%. This represents a significant 292.11% decrease from earnings of $0.76 per share in the same quarter last year.

The company’s quarterly sales of $4.05 billion surpassed the analyst consensus estimate of $3.55 billion by 14.06%. The decline in earnings was primarily attributed to reduced volumes and lower average margins during the fourth quarter of 2022 compared to the same period in 2021.

Delek US also reported a net loss of $118.7 million for the fourth quarter, equivalent to $1.73 per share, but managed to achieve an adjusted net income of $60.8 million or $0.88 per share.

During the fourth quarter, Delek US repurchased approximately 2.8 million shares of common stock for around $89.6 million and raised its quarterly regular dividend by $0.01 to $0.22 per share. As of December 31, 2022, the company had a cash balance of $841.3 million and total consolidated long-term debt of $3,053.7 million.

Looking forward, Delek US is optimistic about seizing market opportunities, particularly in refining, with no significant planned downtime scheduled until late 2024. The company is actively engaged in cost reduction efforts and strategic initiatives aimed at enhancing shareholder value.

Investors seeking more in-depth financial information and updates on Delek US Holdings can participate in their earnings conference calls and access relevant materials on the company’s website.

DK Stock Performance on February 27, 2024: Mixed Results with Positive Momentum

On February 27, 2024, DK stock exhibited mixed performances based on the information provided by CNN Money. The stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating a positive trend in the stock’s price momentum.

The price of DK shares increased by $0.03 since the market last closed, representing a modest 0.11% rise. The stock closed at $28.29 on the previous trading day. However, in pre-market trading, the stock dropped by $0.78, which may indicate some volatility and uncertainty in the stock’s performance for the day ahead.

DK Stock Shows Impressive Financial Performance with 90% Revenue Increase in 2024

On February 27, 2024, DK stock showed impressive performances based on the financial data provided by CNN Money. The company reported a total revenue of $20.25 billion over the past year, which represents a significant increase of 90.13% compared to the previous year. Additionally, the total revenue for the last quarter was $4.75 billion, showing a 13.18% increase since the previous quarter.

Furthermore, DK reported a net income of $257.10 million over the past year, marking a substantial increase of 226.34% compared to the previous year. The net income for the last quarter was $128.70 million, showing an impressive increase of 1650.6% since the previous quarter.

Earnings per share (EPS) for DK stock were reported at $3.60 over the past year, reflecting a notable increase of 230.7% compared to the previous year. The EPS for the last quarter was $1.97, showing a remarkable increase of 1657.77% since the previous quarter.

Investors may view these positive financial indicators as a sign of the company’s growth and profitability, potentially leading to increased interest and investment in DK stock.

Tags: DK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Apellis Pharmaceuticals Reports Quarterly Loss and Revenue Growth in Q4 2023

Ligand Pharmaceuticals Reports Strong Fourth Quarter Earnings and Sales Performance

MA stock news

LendingTree Reports Mixed Results in Latest Earnings Report

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com